In this setting, IL-6 has proven effective in favoring immune system escape by providing a platelet protective shield to tumor cells [101], stimulating platelet production [102], providing growth factors, and promoting tumor angiogenesis via vascular endothelial growth factor (VEGF) [100], all concurring to induce a prothrombotic condition. Here, VEGFA is linked to neoplasm.